Internal Medicine, Medical Oncology · Beckley, WV
NPI
1518955913
Since 2005
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
275 Dry Hill Rd
Beckley, WV, 25801
Phone (304) 253-6060
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.7M
136,296 services
Medicare patients, 2024
662
Average age 73
Drug cost, 2024
$8.7M
3,203 prescriptions
Company payments, 2025
$1,560
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rajiv Khanna was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 13,495 times for 114 patients. In total Rajiv Khanna billed 136,296 services in 145 codes, and Medicare paid $1.7M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-05-15.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 13,495 | 114 | $0.10 | $1,321 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 12,008 | 24 | $44.49 | $534K |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 10,200 | 15 | $0.29 | $3,003 |
| J1453 Injection, fosaprepitant, 1 mg | Office | 8,850 | 25 | $0.11 | $933 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,510 | 50 | $0.81 | $1,229 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,340 | 41 | $0.09 | $124 |
| 99213 Office E&M - Established | Office | 607 | 397 | $64.64 | $39K |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 490 | 12 | $3.77 | $1,849 |
| 36415 Venipuncture Blood Collection | Office | 488 | 103 | $8.62 | $4,208 |
| 85025 Blood Count | Office | 446 | 101 | $7.59 | $3,386 |
| J9190 Injection, fluorouracil, 500 mg | Office | 404 | 15 | $2.41 | $975 |
| 80053 Clinical Chemistry | Office | 353 | 93 | $10.31 | $3,640 |
| 96375 Injection Administration | Office | 325 | 60 | $11.67 | $3,791 |
| 96372 Injection Administration | Office | 286 | 62 | $11.16 | $3,192 |
| 96413 Chemotherapy Administration | Office | 279 | 83 | $95.54 | $27K |
By year: 2022 $3.4M for 377,304 services; 2023 $3.7M for 372,400 services; 2024 $1.7M for 136,296 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 488 | 103 | $8.62 | $4,208 |
| 85025 Blood Count | 446 | 101 | $7.59 | $3,386 |
| 80053 Clinical Chemistry | 353 | 93 | $10.31 | $3,640 |
| 84443 Clinical Chemistry | 79 | 29 | $16.12 | $1,273 |
| 84439 Clinical Chemistry | 69 | 25 | $8.64 | $596 |
| 83615 Clinical Chemistry | 45 | 26 | $5.92 | $266 |
| 86300 Immunoassay | 29 | 15 | $20.39 | $591 |
| 82728 Clinical Chemistry | 25 | 21 | $13.36 | $334 |
| 82607 Clinical Chemistry | 11 | 11 | $14.78 | $163 |
Medicare prescription drug claims, 2024
In 2024, the drug Rajiv Khanna prescribed most often to Medicare patients was Warfarin Sodium, with 405 prescriptions and refills. In total Rajiv Khanna wrote 3,203 Medicare prescriptions that cost $8.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Warfarin Sodium Generic | 405 | 649 | 41 | $2,420 |
| Ondansetron Hcl Generic | 208 | 227 | 93 | $2,525 |
| Anastrozole Generic | 167 | 342 | 43 | $2,597 |
| Eliquis Apixaban | 135 | 181 | 31 | $103K |
| Promethazine Hcl Generic | 100 | 100 | 54 | $886 |
| Prednisone Generic | 100 | 134 | 42 | $549 |
| Levothyroxine Sodium Generic | 99 | 141 | 20 | $721 |
| Hydroxyurea Generic | 90 | 162 | 21 | $2,691 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 79 | 79 | 33 | $1,117 |
| Acyclovir Generic | 77 | 134 | 19 | $1,211 |
| Dexamethasone Generic | 76 | 94 | 47 | $2,136 |
| Abiraterone Acetate Generic | 65 | 65 | Under 11 | $310K |
| Verzenio Abemaciclib | 62 | 62 | Under 11 | $773K |
| Jakafi Ruxolitinib Phosphate | 62 | 62 | Under 11 | $971K |
| Zarxio Filgrastim-Sndz | 61 | 61 | 15 | $166K |
Brand drugs: - claims; generic drugs: 2,246 claims; opioid claims: 206.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rajiv Khanna $1,560 ($1,560 in general payments such as food, travel and fees) from 25 companies. The largest payer was Novartis Pharmaceuticals Corporation with $526.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 14 | $526 |
| Fennec Pharmaceuticals, Inc. FENC | 1 | $139 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $136 |
| GlaxoSmithKline, LLC. GSK | 2 | $114 |
| Janssen Biotech, Inc. JNJ | 3 | $85.85 |
| Celgene Corporation BMY | 3 | $56.61 |
| Eisai Inc. 4523.T | 2 | $45.41 |
| Abbvie Inc. ABBV | 3 | $44.31 |
| Geron Corporation GERN | 2 | $42.8 |
| Pfizer Inc. PFE | 2 | $39.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.